nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—Paraesthesia NEC—Riluzole—amyotrophic lateral sclerosis	0.154	0.222	CcSEcCtD
Zoledronate—FDPS—jaw skeleton—amyotrophic lateral sclerosis	0.0579	0.224	CbGeAlD
Zoledronate—Prostate cancer—Riluzole—amyotrophic lateral sclerosis	0.0384	0.0553	CcSEcCtD
Zoledronate—GGPS1—hindbrain—amyotrophic lateral sclerosis	0.0307	0.119	CbGeAlD
Zoledronate—Panophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.0302	0.0434	CcSEcCtD
Zoledronate—Tetany—Riluzole—amyotrophic lateral sclerosis	0.0226	0.0325	CcSEcCtD
Zoledronate—Osteonecrosis—Riluzole—amyotrophic lateral sclerosis	0.0198	0.0285	CcSEcCtD
Zoledronate—Stiffness—Riluzole—amyotrophic lateral sclerosis	0.0194	0.0279	CcSEcCtD
Zoledronate—GGPS1—brainstem—amyotrophic lateral sclerosis	0.0176	0.0681	CbGeAlD
Zoledronate—Endophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.0155	0.0223	CcSEcCtD
Zoledronate—GGPS1—medulla oblongata—amyotrophic lateral sclerosis	0.0123	0.0475	CbGeAlD
Zoledronate—GGPS1—spinal cord—amyotrophic lateral sclerosis	0.011	0.0423	CbGeAlD
Zoledronate—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.0104	0.015	CcSEcCtD
Zoledronate—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.00962	0.0138	CcSEcCtD
Zoledronate—GGPS1—nervous system—amyotrophic lateral sclerosis	0.00923	0.0357	CbGeAlD
Zoledronate—GGPS1—central nervous system—amyotrophic lateral sclerosis	0.00888	0.0343	CbGeAlD
Zoledronate—GGPS1—cerebellum—amyotrophic lateral sclerosis	0.00868	0.0336	CbGeAlD
Zoledronate—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00821	0.0118	CcSEcCtD
Zoledronate—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00816	0.0117	CcSEcCtD
Zoledronate—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00774	0.0111	CcSEcCtD
Zoledronate—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00746	0.0107	CcSEcCtD
Zoledronate—CA2—hindbrain—amyotrophic lateral sclerosis	0.00735	0.0284	CbGeAlD
Zoledronate—CA14—medulla oblongata—amyotrophic lateral sclerosis	0.00734	0.0284	CbGeAlD
Zoledronate—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00732	0.0105	CcSEcCtD
Zoledronate—GGPS1—brain—amyotrophic lateral sclerosis	0.00705	0.0273	CbGeAlD
Zoledronate—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00703	0.0101	CcSEcCtD
Zoledronate—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00666	0.00959	CcSEcCtD
Zoledronate—CA14—spinal cord—amyotrophic lateral sclerosis	0.00655	0.0253	CbGeAlD
Zoledronate—FDPS—medulla oblongata—amyotrophic lateral sclerosis	0.00566	0.0219	CbGeAlD
Zoledronate—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00564	0.00812	CcSEcCtD
Zoledronate—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00562	0.00809	CcSEcCtD
Zoledronate—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.0055	0.00792	CcSEcCtD
Zoledronate—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00535	0.0077	CcSEcCtD
Zoledronate—CA14—cerebellum—amyotrophic lateral sclerosis	0.00519	0.0201	CbGeAlD
Zoledronate—FDPS—spinal cord—amyotrophic lateral sclerosis	0.00505	0.0195	CbGeAlD
Zoledronate—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00497	0.00716	CcSEcCtD
Zoledronate—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00487	0.007	CcSEcCtD
Zoledronate—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00473	0.00681	CcSEcCtD
Zoledronate—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00472	0.00679	CcSEcCtD
Zoledronate—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00465	0.0067	CcSEcCtD
Zoledronate—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00462	0.00665	CcSEcCtD
Zoledronate—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00462	0.00665	CcSEcCtD
Zoledronate—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00462	0.00665	CcSEcCtD
Zoledronate—CA2—embryo—amyotrophic lateral sclerosis	0.0046	0.0178	CbGeAlD
Zoledronate—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00443	0.00638	CcSEcCtD
Zoledronate—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00439	0.00632	CcSEcCtD
Zoledronate—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00432	0.00622	CcSEcCtD
Zoledronate—CA12—nervous system—amyotrophic lateral sclerosis	0.0043	0.0166	CbGeAlD
Zoledronate—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00427	0.00615	CcSEcCtD
Zoledronate—FDPS—nervous system—amyotrophic lateral sclerosis	0.00425	0.0164	CbGeAlD
Zoledronate—CA14—brain—amyotrophic lateral sclerosis	0.00422	0.0163	CbGeAlD
Zoledronate—CA2—brainstem—amyotrophic lateral sclerosis	0.00421	0.0163	CbGeAlD
Zoledronate—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00421	0.00605	CcSEcCtD
Zoledronate—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00418	0.00602	CcSEcCtD
Zoledronate—Risedronate—PTGS2—amyotrophic lateral sclerosis	0.00416	0.529	CrCbGaD
Zoledronate—CA12—central nervous system—amyotrophic lateral sclerosis	0.00414	0.016	CbGeAlD
Zoledronate—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00412	0.00593	CcSEcCtD
Zoledronate—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00412	0.00593	CcSEcCtD
Zoledronate—Depression—Riluzole—amyotrophic lateral sclerosis	0.00411	0.00591	CcSEcCtD
Zoledronate—FDPS—central nervous system—amyotrophic lateral sclerosis	0.0041	0.0158	CbGeAlD
Zoledronate—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00402	0.00578	CcSEcCtD
Zoledronate—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00401	0.00577	CcSEcCtD
Zoledronate—FDPS—cerebellum—amyotrophic lateral sclerosis	0.004	0.0155	CbGeAlD
Zoledronate—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00393	0.00566	CcSEcCtD
Zoledronate—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00385	0.00554	CcSEcCtD
Zoledronate—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00542	CcSEcCtD
Zoledronate—Clodronate—PTGS2—amyotrophic lateral sclerosis	0.00371	0.471	CrCbGaD
Zoledronate—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00368	0.0053	CcSEcCtD
Zoledronate—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00526	CcSEcCtD
Zoledronate—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00525	CcSEcCtD
Zoledronate—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00364	0.00523	CcSEcCtD
Zoledronate—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00363	0.00522	CcSEcCtD
Zoledronate—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00498	CcSEcCtD
Zoledronate—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00343	0.00494	CcSEcCtD
Zoledronate—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00483	CcSEcCtD
Zoledronate—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00334	0.00481	CcSEcCtD
Zoledronate—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00333	0.0048	CcSEcCtD
Zoledronate—Chills—Riluzole—amyotrophic lateral sclerosis	0.00332	0.00478	CcSEcCtD
Zoledronate—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00476	CcSEcCtD
Zoledronate—CA12—brain—amyotrophic lateral sclerosis	0.00329	0.0127	CbGeAlD
Zoledronate—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00327	0.00471	CcSEcCtD
Zoledronate—FDPS—brain—amyotrophic lateral sclerosis	0.00325	0.0126	CbGeAlD
Zoledronate—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00324	0.00466	CcSEcCtD
Zoledronate—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00464	CcSEcCtD
Zoledronate—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00315	0.00454	CcSEcCtD
Zoledronate—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00312	0.00448	CcSEcCtD
Zoledronate—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.0031	0.00446	CcSEcCtD
Zoledronate—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00302	0.00434	CcSEcCtD
Zoledronate—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00299	0.0043	CcSEcCtD
Zoledronate—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00428	CcSEcCtD
Zoledronate—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00296	0.00426	CcSEcCtD
Zoledronate—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00424	CcSEcCtD
Zoledronate—CA2—medulla oblongata—amyotrophic lateral sclerosis	0.00294	0.0114	CbGeAlD
Zoledronate—Malaise—Riluzole—amyotrophic lateral sclerosis	0.0029	0.00418	CcSEcCtD
Zoledronate—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00416	CcSEcCtD
Zoledronate—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00416	CcSEcCtD
Zoledronate—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00415	CcSEcCtD
Zoledronate—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00285	0.0041	CcSEcCtD
Zoledronate—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00407	CcSEcCtD
Zoledronate—Cough—Riluzole—amyotrophic lateral sclerosis	0.00281	0.00404	CcSEcCtD
Zoledronate—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00279	0.00402	CcSEcCtD
Zoledronate—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00278	0.004	CcSEcCtD
Zoledronate—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00395	CcSEcCtD
Zoledronate—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00395	CcSEcCtD
Zoledronate—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00395	CcSEcCtD
Zoledronate—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00393	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00272	0.00392	CcSEcCtD
Zoledronate—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00271	0.0039	CcSEcCtD
Zoledronate—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00386	CcSEcCtD
Zoledronate—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00381	CcSEcCtD
Zoledronate—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00378	CcSEcCtD
Zoledronate—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00378	CcSEcCtD
Zoledronate—CA2—spinal cord—amyotrophic lateral sclerosis	0.00262	0.0101	CbGeAlD
Zoledronate—Infection—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00376	CcSEcCtD
Zoledronate—Shock—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00372	CcSEcCtD
Zoledronate—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00371	CcSEcCtD
Zoledronate—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00257	0.0037	CcSEcCtD
Zoledronate—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00257	0.00369	CcSEcCtD
Zoledronate—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00367	CcSEcCtD
Zoledronate—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00366	CcSEcCtD
Zoledronate—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00361	CcSEcCtD
Zoledronate—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00353	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00345	CcSEcCtD
Zoledronate—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00342	CcSEcCtD
Zoledronate—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00236	0.0034	CcSEcCtD
Zoledronate—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00337	CcSEcCtD
Zoledronate—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00336	CcSEcCtD
Zoledronate—ABCC1—cerebellum—amyotrophic lateral sclerosis	0.00232	0.00899	CbGeAlD
Zoledronate—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00333	CcSEcCtD
Zoledronate—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00229	0.00329	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00327	CcSEcCtD
Zoledronate—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00326	CcSEcCtD
Zoledronate—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00324	CcSEcCtD
Zoledronate—Pain—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00324	CcSEcCtD
Zoledronate—CA2—nervous system—amyotrophic lateral sclerosis	0.00221	0.00854	CbGeAlD
Zoledronate—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00312	CcSEcCtD
Zoledronate—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00309	CcSEcCtD
Zoledronate—CA2—central nervous system—amyotrophic lateral sclerosis	0.00213	0.00822	CbGeAlD
Zoledronate—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00209	0.00301	CcSEcCtD
Zoledronate—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00299	CcSEcCtD
Zoledronate—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00299	CcSEcCtD
Zoledronate—CA2—cerebellum—amyotrophic lateral sclerosis	0.00208	0.00803	CbGeAlD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00197	0.0512	CbGpPWpGaD
Zoledronate—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00279	CcSEcCtD
Zoledronate—ABCC1—brain—amyotrophic lateral sclerosis	0.00189	0.0073	CbGeAlD
Zoledronate—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00271	CcSEcCtD
Zoledronate—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00268	CcSEcCtD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00181	0.0468	CbGpPWpGaD
Zoledronate—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00259	CcSEcCtD
Zoledronate—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00174	0.0025	CcSEcCtD
Zoledronate—CA2—brain—amyotrophic lateral sclerosis	0.00169	0.00653	CbGeAlD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00168	0.0436	CbGpPWpGaD
Zoledronate—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00241	CcSEcCtD
Zoledronate—Rash—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00239	CcSEcCtD
Zoledronate—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00238	CcSEcCtD
Zoledronate—Headache—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00237	CcSEcCtD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00158	0.0409	CbGpPWpGaD
Zoledronate—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00225	CcSEcCtD
Zoledronate—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—TPK1—amyotrophic lateral sclerosis	0.00135	0.0351	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00108	0.0281	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000879	0.0228	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000879	0.0228	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000843	0.0219	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00082	0.0213	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000804	0.0209	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000771	0.02	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000748	0.0194	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000717	0.0186	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000703	0.0182	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000674	0.0175	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000636	0.0165	CbGpPWpGaD
Zoledronate—ABCC1—S1P1 pathway—PTGS2—amyotrophic lateral sclerosis	0.000528	0.0137	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000482	0.0125	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000462	0.012	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000445	0.0115	CbGpPWpGaD
Zoledronate—ABCC1—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000432	0.0112	CbGpPWpGaD
Zoledronate—CA14—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000429	0.0111	CbGpPWpGaD
Zoledronate—CA14—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000429	0.0111	CbGpPWpGaD
Zoledronate—ABCC1—S1P1 pathway—VEGFA—amyotrophic lateral sclerosis	0.000416	0.0108	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000405	0.0105	CbGpPWpGaD
Zoledronate—CA14—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000393	0.0102	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000375	0.00974	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000375	0.00974	CbGpPWpGaD
Zoledronate—CA14—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000365	0.00947	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000365	0.00947	CbGpPWpGaD
Zoledronate—CA12—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000362	0.00939	CbGpPWpGaD
Zoledronate—CA12—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000362	0.00939	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00035	0.00908	CbGpPWpGaD
Zoledronate—CA14—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000343	0.00891	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000343	0.00891	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000333	0.00864	CbGpPWpGaD
Zoledronate—CA12—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000331	0.00859	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000319	0.00828	CbGpPWpGaD
Zoledronate—CA14—Metabolism—DAO—amyotrophic lateral sclerosis	0.000311	0.00805	CbGpPWpGaD
Zoledronate—CA12—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000308	0.00798	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000301	0.0078	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—FIG4—amyotrophic lateral sclerosis	0.0003	0.00778	CbGpPWpGaD
Zoledronate—CA12—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000289	0.00751	CbGpPWpGaD
Zoledronate—CA2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000277	0.00718	CbGpPWpGaD
Zoledronate—CA2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000277	0.00718	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000275	0.00714	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—DAO—amyotrophic lateral sclerosis	0.000271	0.00704	CbGpPWpGaD
Zoledronate—CA12—Metabolism—DAO—amyotrophic lateral sclerosis	0.000262	0.00679	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000256	0.00664	CbGpPWpGaD
Zoledronate—CA2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000253	0.00657	CbGpPWpGaD
Zoledronate—ABCC1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000243	0.00631	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000241	0.00624	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000235	0.0061	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000235	0.0061	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000228	0.00592	CbGpPWpGaD
Zoledronate—CA2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000221	0.00574	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GSR—amyotrophic lateral sclerosis	0.000217	0.00563	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000217	0.00562	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000206	0.00534	CbGpPWpGaD
Zoledronate—CA2—Metabolism—DAO—amyotrophic lateral sclerosis	0.0002	0.00519	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000198	0.00514	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000196	0.00509	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GSR—amyotrophic lateral sclerosis	0.00019	0.00492	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GSR—amyotrophic lateral sclerosis	0.000183	0.00475	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00018	0.00468	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000178	0.00463	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000173	0.00448	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000165	0.00428	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TPK1—amyotrophic lateral sclerosis	0.00016	0.00415	CbGpPWpGaD
Zoledronate—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—amyotrophic lateral sclerosis	0.000156	0.00405	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000156	0.00404	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000152	0.00393	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00015	0.0039	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000148	0.00385	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000142	0.00369	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSR—amyotrophic lateral sclerosis	0.00014	0.00363	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00014	0.00362	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000134	0.00348	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000134	0.00348	CbGpPWpGaD
Zoledronate—ABCC1—Disease—VTA1—amyotrophic lateral sclerosis	0.000128	0.00332	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000125	0.00324	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000123	0.00318	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000119	0.00308	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000119	0.00308	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000115	0.00298	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000114	0.00295	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000107	0.00278	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000106	0.00275	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000102	0.00264	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.75e-05	0.00253	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CHMP2B—amyotrophic lateral sclerosis	9.69e-05	0.00251	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—DAO—amyotrophic lateral sclerosis	9.69e-05	0.00251	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.59e-05	0.00249	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.81e-05	0.00228	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PLB1—amyotrophic lateral sclerosis	8.77e-05	0.00227	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.38e-05	0.00217	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.08e-05	0.0021	CbGpPWpGaD
Zoledronate—ABCC1—Disease—VCP—amyotrophic lateral sclerosis	7.81e-05	0.00203	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.7e-05	0.002	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.42e-05	0.00193	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PLB1—amyotrophic lateral sclerosis	7.34e-05	0.0019	CbGpPWpGaD
Zoledronate—CA14—Metabolism—APOE—amyotrophic lateral sclerosis	7.25e-05	0.00188	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSR—amyotrophic lateral sclerosis	6.77e-05	0.00176	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—APOE—amyotrophic lateral sclerosis	6.33e-05	0.00164	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.18e-05	0.0016	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.17e-05	0.0016	CbGpPWpGaD
Zoledronate—CA12—Metabolism—APOE—amyotrophic lateral sclerosis	6.11e-05	0.00158	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.68e-05	0.00147	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CST3—amyotrophic lateral sclerosis	5.61e-05	0.00145	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CHAT—amyotrophic lateral sclerosis	5.56e-05	0.00144	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.08e-05	0.00132	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.97e-05	0.00129	CbGpPWpGaD
Zoledronate—CA2—Metabolism—APOE—amyotrophic lateral sclerosis	4.67e-05	0.00121	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.34e-05	0.00113	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.19e-05	0.00109	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CASP9—amyotrophic lateral sclerosis	4.08e-05	0.00106	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ERBB4—amyotrophic lateral sclerosis	3.49e-05	0.000905	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.48e-05	0.000902	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.2e-05	0.00083	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.99e-05	0.000776	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.75e-05	0.000713	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APOE—amyotrophic lateral sclerosis	2.7e-05	0.0007	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APOE—amyotrophic lateral sclerosis	2.26e-05	0.000586	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTGS2—amyotrophic lateral sclerosis	1.85e-05	0.00048	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.55e-05	0.000402	CbGpPWpGaD
